Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex
- PMID: 12542793
- DOI: 10.1046/j.1365-3083.2003.01176.x
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex
Abstract
We aimed to study the effects of mesenchymal stem cells (MSCs) on alloreactivity and effects of T-cell activation on human peripheral blood lymphocytes (PBLs) in vitro. MSCs were expanded from the bone marrow of healthy subjects. MSCs isolated from second to third passage were positive for CD166, CD105, CD44, CD29, SH-3 and SH-4, but negative for CD34 and CD45. MSCs cultured in osteogenic, adipogenic or chondrogenic media differentiated, respectively, into osteocytes, adipocytes or chondrocytes. MSC added to PBL cultures had various effects, ranging from slight inhibition to stimulation of DNA synthesis. The stimulation index (SI = (PBL + MSC)/PBL) varied between 0.2 and 7.3. The SI was not affected by the MSC dose or by the addition of allogeneic or autologous MSCs to the lymphocytes. Suppression of proliferative activity was observed in all experiments after the addition of 10,000-40,000 MSCs to mixed lymphocyte cultures (MLCs). Lymphocyte proliferation was 10-90%, compared with a control MLC run in parallel without MSCs. In contrast, the addition of fewer MSCs (10-1000 cells) led to a less consistent suppression or a marked lymphocyte proliferation in several experiments, ranging from 40 to 190% of the maximal lymphocyte proliferation in control MLCs. The ability to inhibit or stimulate T-cell alloresponses appeared to be independent of the major histocompatibility complex, as results were similar using 'third party' MSCs or MSCs that were autologous to the responder or stimulating PBLs. The strongest inhibitory effect was seen if MSCs were added at the beginning of the 6 day culture, and the effect declined if MSCs were added on day 3 or 5. Marked inhibitory effects of allogeneic and autologous MSCs (15,000) were also noted after mitogenic lymphocyte stimulation by phytohaemagglutinin (median lymphocyte proliferation of 30% of controls), Concanavalin A (56%) and protein A (65%). Little, if any, inhibition occurred after stimulation with pokeweed mitogen. Low numbers of MSCs (150 cells) were unable to inhibit mitogen-induced T-cell responses. MSCs have significant immune modulatory effects on MLCs and after mitogenic stimulation of PBL. High numbers of MSCs suppress alloreactive T cells, whereas very low numbers clearly stimulated lymphocyte proliferation in some experiments. The effect of a larger number of MSCs on MLCs seems more dependent on cell dose than histocompatibility and could result from an 'overload' of a stimulatory mechanism.
Similar articles
-
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells.Bone Marrow Transplant. 2003 Aug;32(3):265-72. doi: 10.1038/sj.bmt.1704111. Bone Marrow Transplant. 2003. PMID: 12858197
-
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.Exp Cell Res. 2005 Apr 15;305(1):33-41. doi: 10.1016/j.yexcr.2004.12.013. Epub 2005 Jan 25. Exp Cell Res. 2005. PMID: 15777785
-
Immunologic properties of human fetal mesenchymal stem cells.Am J Obstet Gynecol. 2004 Jan;190(1):239-45. doi: 10.1016/j.ajog.2003.07.022. Am J Obstet Gynecol. 2004. PMID: 14749666
-
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.Exp Hematol. 2003 Oct;31(10):890-6. doi: 10.1016/s0301-472x(03)00110-3. Exp Hematol. 2003. PMID: 14550804
-
Mesenchymal stem cells: building blocks for molecular medicine in the 21st century.Trends Mol Med. 2001 Jun;7(6):259-64. doi: 10.1016/s1471-4914(01)02016-0. Trends Mol Med. 2001. PMID: 11378515 Review.
Cited by
-
Mesenchymal stem cell transplantation in multiple sclerosis.J Neurol Sci. 2013 Oct 15;333(1-2):43-9. doi: 10.1016/j.jns.2012.12.009. Epub 2013 Jan 4. J Neurol Sci. 2013. PMID: 23294498 Free PMC article. Review.
-
CTLA4 enhances the osteogenic differentiation of allogeneic human mesenchymal stem cells in a model of immune activation.Braz J Med Biol Res. 2015 Jul;48(7):629-36. doi: 10.1590/1414-431X20154209. Epub 2015 May 19. Braz J Med Biol Res. 2015. PMID: 26017342 Free PMC article.
-
Nanospheres Loaded with Curcumin Improve the Bioactivity of Umbilical Cord Blood-Mesenchymal Stem Cells via c-Src Activation During the Skin Wound Healing Process.Cells. 2020 Jun 15;9(6):1467. doi: 10.3390/cells9061467. Cells. 2020. PMID: 32549381 Free PMC article.
-
Human embryonic mesenchymal stem cells participate in differentiation of renal tubular cells in newborn mice.Exp Ther Med. 2016 Aug;12(2):641-648. doi: 10.3892/etm.2016.3383. Epub 2016 May 24. Exp Ther Med. 2016. PMID: 27446255 Free PMC article.
-
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354. Oncotarget. 2016. PMID: 27542276 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous